Successful salvage of recurrent leptomeningeal disease in large cell neuroendocrine lung cancer with stereotactic radiotherapy
- PMID: 34459938
- DOI: 10.1007/s00066-021-01814-0
Successful salvage of recurrent leptomeningeal disease in large cell neuroendocrine lung cancer with stereotactic radiotherapy
Abstract
A 70-year old male with stage I large cell neuroendocrine carcinoma (LCNEC) of the lung underwent resection of a metachronous 5 cm brain metastasis and received postoperative hypofractionated stereotactic radiotherapy (hfSRT). Five sequential nodular leptomeningeal metastases up to 5.3 cm in diameter were diagnosed on MRI within 10 months and were treated with SRT. Currently the patient has no evidence of intracranial disease 24 months after last irradiation without chemotherapy or whole brain radiotherapy. This is the first report of sustained complete remission of multiple large leptomeningeal metastases achieved with hfSRT, highlighting this brain-sparing approach in selected patients with LCNEC lung cancer.
Keywords: Hypo-fractionated radiosurgery; Large cell neuroendocrine carcinoma; Leptomeningeal disease; Radiosurgery.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Asamura H, Kameya T, Matsuno Y et al (2006) Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 24(1):70–76 - PubMed
-
- Aupérin A, Arriagada R, Pignon JP et al (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 341(7):476–484 - PubMed
-
- Bene GD, Prelaj A, Berrios JRG, Filippis LD, Emiliani A, Galletti A, Ferrara C, Longo F (2016) 94P: first-line treatment with cisplatin plus etoposide for small cell lung cancer and large cell neuroendocrine carcinoma: our center experience. J Thorac Oncol 11(4):S97
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical